Wharton Professor Talks About the Major Hurdles in Marijuana Legalization
The marijuana industry is on the top of the minds of policymakers across the United States. There are so many things to consider, one of the most critical policies being banking regulation. And with former Republican Speaker of the United States House of Representatives, John Boehner, as a confounding new pro-marijuana spokesman, it seems as if there’s never been a more apt time to discuss marijuana legalization and policy.
That’s why University of Pennsylvania Wharton School professor Peter Conti-Brown dove deep into the marijuana industry to discuss the many policy barriers that are causing issues. In particular, he looked how the government’s current stance on marijuana is causing more trouble than it’s solving when it comes to banking. Continue reading…
UCLA Anderson Professor Explains Why Drug Prices Are So High
When drug prices go through astronomical price surges, a lot of blame goes around.
Sloan Alum Startup twoXAR Uses Big Data to Connect Diseases with Drugs
MIT Sloan School of Management recently published an article on biopharmaceutical firm twoXAR (pronounced “two czar”), launched by Sloan alumnus Andrew M. Radin (MBA ‘14) and Andrew A. Radin (no relation). The firm takes a big data approach to scan “the handful of drug candidates out of a drug library of thousands, if not millions, that would most effectively treat a specific disease.”
Continue reading…
